Particle.news

Download on the App Store

Lawmaker Draws Ethics Scrutiny for Selling Centene Stock Before Medicaid Vote

Democrats are calling for a congressional stock trading ban after Pennsylvania Republican Robert Bresnahan unloaded Centene shares ahead of a vote enacting $1 trillion in Medicaid cuts

Overview

  • As of early July, Bresnahan has not established the qualified blind trust he promised to separate his personal investments from his congressional duties
  • Centene’s stock remains about 43 percent below its pre-sale value after plunging in late June following his May share sale
  • On July 3, Bresnahan voted to approve President Trump’s fiscal 2026 budget, cementing Medicaid reductions over the next decade
  • Senators Elizabeth Warren and Representatives Maxwell Frost and Melanie Stansbury have publicly condemned his timing and urged stricter congressional ethics rules
  • Roughly 27 percent of residents in Bresnahan’s Pennsylvania district rely on Medicaid, underscoring the local impact of the federal funding cuts